|
2008
|
The periodontal pathogen Porphyromonas gingivalis sensitises human blood platelets to epinephrine | ||||||||
|
Nylander M, Lindahl TL, Bengtsson T, Grenegård M
|
|||||||||
|
Platelets 19(5):352-8
|
|||||||||
|
2008
|
A possible ethanol-catalyzed rearrangement of vitamin K(1) detected by gas chromatography/mass spectrometry | ||||||||
|
Osman A, Hannestad U
|
|||||||||
|
Rapid Commun Mass Spectrom 22(23):3861-6
|
|||||||||
|
2007
|
Plasma S/R ratio of warfarin co-varies with VKORC1 haplotype | ||||||||
|
Osman A, Enstrom C, Lindahl TL.
|
|||||||||
|
Blood Coagul Fibrinolysis 18(3):293-6
|
|||||||||
|
2007
|
Osäkert prognostiskt värde av förhöjd trombinbildning | ||||||||
|
Lindahl TL.
|
|||||||||
|
Läkartidningen 104:315
|
|||||||||
|
2007
|
Inverse relationship between the severity of gingivitis and platelet reactivity in stable angina pectoris | ||||||||
|
Järemo P, Starkhammar C, Lundström A, Lindahl TL, Richter A.
|
|||||||||
|
J Thromb Haemost 5:422-3
|
|||||||||
|
2007
|
Plasma S/R ratio of warfarin co-varies with VKORC1 haplotype | ||||||||
|
Osman M, Enstrom C, Lindahl TL
|
|||||||||
|
Blood Coagul Fibrinolysis 18:293-6
|
|||||||||
|
2007
|
Detection of surface bound complement at increasing serum anticoagulant concentrations | ||||||||
|
Arvidsson S, Askendal A, Lindahl TL, Tengvall P
|
|||||||||
|
Colloids Surf B Biointerfaces 62(2):214-9
|
|||||||||
|
2007
|
Imaging of blood plasma coagulation and its propagation at surfaces | ||||||||
|
Faxälv L, Tengvall P, Lindahl TL
|
|||||||||
|
J Biomed Mater Res A
|
|||||||||
|
2007
|
A genotyping method for VKORC1 1173C>T by Pyrosequencing® technology | ||||||||
|
Enstrom C, Osman A, Lindahl TL
|
|||||||||
|
Scand J Clin Lab Invest 68(5):427-430
|
|||||||||
|
2006
|
Characterisation of species differences in the platelet ADP and thrombin response | ||||||||
|
S. Nylander, C. Mattsson and T. L. Lindahl
|
|||||||||
|
Thromb Res 117(5):543-9
|
|||||||||
|
2006
|
Evaluation of platelet function, a method comparison | ||||||||
|
S. Nylander, K. Johansson, J. J. Van Giezen and T. L. Lindahl
|
|||||||||
|
Platelets 17(1):49-55
|
|||||||||
|
2006
|
Effects of different blood components on clot retraction analysed by measuring elasticity with a free oscillating rheometer | ||||||||
|
Tynngård N, Lindahl T, Ramström S, Berlin G.
|
|||||||||
|
Platelets 17:545-54.
|
|||||||||
|
2005
|
A new high-performance liquid chromatographic method for determination of warfarin enantiomers | ||||||||
|
A. Osman, K. Arbring and T. L. Lindahl
|
|||||||||
|
J Chromatogr B Analyt Technol Biomed Life Sci 826(1-2):75-80
|
|||||||||
|
2005
|
Clotting time analysis of citrated blood samples is strongly affected by the tube used for blood sampling | ||||||||
|
Ramström S.
|
|||||||||
|
Blood Coagul Fibrinolysis 16:447-452.
|
|||||||||
|
2003
|
The relative importance of the ADP receptors, P2Y12 and P2Y1, in thrombin-induced platelet activation | ||||||||
|
S. Nylander, C. Mattsson, S. Ramstrom and T. L. Lindahl
|
|||||||||
|
Thromb Res 111(1-2):65-73
|
|||||||||
|
2003
|
A new flow cytometric method for measurement of von Willebrand factor activity | ||||||||
|
T. L. Lindahl, I. H. Fagerberg and A. Larsson
|
|||||||||
|
Scand J Clin Lab Invest 63(3):217-23
|
|||||||||
|
2003
|
A critical evaluation of the prothrombin time for monitoring oral anticoagulant therapy | ||||||||
|
C. M. Jackson, M. P. Esnouf and T. L. Lindahl
|
|||||||||
|
Pathophysiol Haemost Thromb 33(1):43-51
|
|||||||||
|
2002
|
Studies of fibrinogen binding to porcine platelets by flow cytometry: a method for studies of porcine platelet activation | ||||||||
|
A. Larsson, M. Eriksson and T. L. Lindahl
|
|||||||||
|
Platelets 13(3):153-7
|
|||||||||
|
2002
|
Anticoagulant therapy at four hospitals in Ostergotland--quality control using a shared computer program | ||||||||
|
S. Karlander and T. L. Lindahl
|
|||||||||
|
Lakartidningen 99(14):1592-4, 1597-8
|
|||||||||
|
2002
|
Individual variations of platelet inhibition after loading doses of clopidogrel | ||||||||
|
P. Jaremo, T. L. Lindahl, S. G. Fransson and A. Richter
|
|||||||||
|
J Intern Med 252(3):233-8
|
|||||||||
|
2002
|
Pharmaceutical thrombosis prevention in cardiovascular disease | ||||||||
|
M. Eriksson, K. Christensen, T. L. Lindahl and A. Larsson
|
|||||||||
|
Expert Opin Investig Drugs 11(4):553-63
|
|||||||||
|
2002
|
ADP activation induces bFGF binding to platelets in vitro | ||||||||
|
B. Akerblom, T. L. Lindahl and A. Larsson
|
|||||||||
|
Ups J Med Sci 107(3):165-71
|
|||||||||
|
2000
|
The use of platelet density and volume measurements to estimate the severity of pre-eclampsia | ||||||||
|
P. Jaremo, T. L. Lindahl, C. Lennmarken and H. Forsgren
|
|||||||||
|
Eur J Clin Invest 30(12):1113-8
|
|||||||||
|
1999
|
Laboratory diagnosis of thrombophilia by endothelial-cell-modulated coagulation | ||||||||
|
M. Ranby, K. M. Gustafsson and T. L. Lindahl
|
|||||||||
|
Blood Coagul Fibrinolysis 10(4):173-9
|
|||||||||
|
1999
|
Isocitrate as calcium ion activity buffer in coagulation assays | ||||||||
|
M. Ranby, T. Gojceta, K. Gustafsson, K. M. Hansson and T. L. Lindahl
|
|||||||||
|
Clin Chem 45(8 Pt 1):1176-80
|
|||||||||
|
1994
|
Inhibition of fibrinogen binding to platelets by MK-852, a new GPIIb/IIIa antagonist | ||||||||
|
A. Larsson and T. L. Lindahl
|
|||||||||
|
Ups J Med Sci 99(2):121-9
|
|||||||||
|
1993
|
Chicken antibodies: taking advantage of evolution--a review | ||||||||
|
A. Larsson, R. M. Balow, T. L. Lindahl and P. O. Forsberg
|
|||||||||
|
Poult Sci 72(10):1807-12
|
|||||||||
|
1992
|
Studies of the platelet fibrinogen receptor in Glanzmann patients and uremic patients | ||||||||
|
T. L. Lindahl, J. Lundahl, C. Netre and N. Egberg
|
|||||||||
|
Thromb Res 67(4):457-66
|
|||||||||
|
1992
|
Studies of fibrinogen binding to platelets by flow cytometry: an improved method for studies of platelet activation | ||||||||
|
T. L. Lindahl, R. Festin and A. Larsson
|
|||||||||
|
Thromb Haemost 68(2):221-5
|
|||||||||
|
1990
|
The mechanism of the reaction between human plasminogen-activator inhibitor 1 and tissue plasminogen activator | ||||||||
|
T. L. Lindahl, P. I. Ohlsson and B. Wiman
|
|||||||||
|
Biochem J 265(1):109-13
|
|||||||||
|
1989
|
Stability of plasminogen activator inhibitor 1 (PAI-1) | ||||||||
|
T. L. Lindahl, O. Sigurdardottir and B. Wiman
|
|||||||||
|
Thromb Haemost 62(2):748-51
|
|||||||||
| Webmaster Lars Faxälv | ||||
| Copyright © 2007 Haemostasis.se | ||||